home / stock / etnb / etnb quote
Last: | $ |
---|---|
Change Percent: | 2.45% |
Open: | $28.80 |
Close: | $29.30 |
High: | $31.19 |
Low: | $27.76 |
Volume: | 11,196 |
Last Trade Date Time: | 02/12/2020 04:44:06 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $28.80 | $29.30 | $31.19 | $27.76 | 11,196 | 02-12-2020 |
$ | $27.31 | $28.60 | $28.85 | $26.32 | 23,681 | 02-11-2020 |
$ | $26.00 | $26.79 | $27.03 | $25.975 | 10,861 | 02-10-2020 |
$ | $27.03 | $25.99 | $27.97 | $25.7352 | 28,923 | 02-07-2020 |
$ | $26.45 | $27.53 | $27.77 | $25.955 | 37,417 | 02-06-2020 |
$ | $27.20 | $26.36 | $29.00 | $26.17 | 64,450 | 02-05-2020 |
$ | $26.05 | $26.90 | $27.9661 | $25.3972 | 54,208 | 02-04-2020 |
$ | $27.00 | $25.90 | $28.84 | $25.261 | 49,774 | 02-03-2020 |
$ | $30.52 | $26.72 | $31.99 | $25.24 | 72,888 | 01-31-2020 |
$ | $34.02 | $30.37 | $35.712 | $29.50 | 74,218 | 01-30-2020 |
$ | $27.83 | $33.66 | $34.93 | $26.76 | 94,874 | 01-29-2020 |
$ | $27.72 | $27.34 | $27.88 | $27.00 | 15,868 | 01-28-2020 |
$ | $25.61 | $27.18 | $28.69 | $25.60 | 30,621 | 01-27-2020 |
$ | $27.80 | $26.15 | $27.835 | $25.80 | 13,544 | 01-24-2020 |
$ | $28.60 | $27.92 | $28.90 | $26.2703 | 28,592 | 01-23-2020 |
$ | $27.10 | $28.21 | $29.48 | $27.095 | 42,240 | 01-22-2020 |
$ | $26.51 | $27.60 | $27.87 | $25.4245 | 28,053 | 01-21-2020 |
$ | $25.63 | $26.51 | $26.8266 | $25.63 | 23,570 | 01-20-2020 |
$ | $25.63 | $26.51 | $26.8266 | $25.63 | 23,570 | 01-17-2020 |
$ | $26.70 | $25.61 | $27.01 | $24.60 | 118,105 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
89bio Inc. Company Name:
ETNB Stock Symbol:
NYSE Market:
2024-04-21 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the developme...
SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the appointment of Martin Babl...